Fresenius SE & Co KGaA (XTER:FRE)
€ 27.75 -0.19 (-0.68%) Market Cap: 15.63 Bil Enterprise Value: 29.17 Bil PE Ratio: 0 PB Ratio: 0.82 GF Score: 75/100

Fresenius SE & Co KGaA at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2020 / 03:20PM GMT
Release Date Price: €44.06 (+0.16%)
Veronika Dubajova
Goldman Sachs Group, Inc., Research Division - Equity Analyst

Good afternoon, good morning, ladies and gentlemen, and thank you for joining us for another session of our 41st Goldman Sachs Global Healthcare Conference webcast. My name is Veronika Dubajova, and I'm the medtech analyst at Goldman Sachs in London. And it is with great pleasure that I am joined today by the management team of Fresenius SE, Stephan Sturm, CEO; and Markus Georgi, Head of IR. Thank you guys for being here and greetings to Bad Homburg.

We are going to conduct the session entirely as Q&A. (Operator Instructions)

So Stephan and Markus, thank you for being here.

Questions & Answers

Veronika Dubajova
Goldman Sachs Group, Inc., Research Division - Equity Analyst

I want to start with the topic du jour, which is Helios and COVID. And this has obviously been a big discussion point for everyone. But can you maybe give us an update on where you are in terms of volume and utilization levels, both in Spain and in Germany? And how has the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot